0001144204-18-001717.txt : 20180216 0001144204-18-001717.hdr.sgml : 20180216 20180110161530 ACCESSION NUMBER: 0001144204-18-001717 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 20 FIRSTFIELD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 CORRESP 1 filename1.htm

NOVAVAX, INC.

20 Firstfield Road

Gaithersburg, MD 20878

January 10, 2018

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

450 Fifth Street, N.W.

Washington, D.C. 20549

Attention:		Christine Westbrook

	Re:	Novavax, Inc.
		Registration Statement on Form S-3 (File No. 333-222365)
		Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Novavax, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-222365) (the “Registration Statement”), so that it will be declared effective at 4:00 p.m. Eastern Time on January 12, 2018, or as soon as possible thereafter. The Company hereby authorizes Paul Kinsella and John Donnelly of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.

It would be appreciated if, as soon as the Registration Statement is declared effective, you would inform John Donnelly of Ropes & Gray LLP, counsel to the Company, at (617) 235-4773.

	Very truly yours,

	NOVAVAX, INC.

	By:	/s/ John Herrmann
		John Herrmann
		Corporate Secretary